Digest Network Come funziona
Network
/
Società
Am
Non verificato

Amylyx Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteWeb e Social Network

65 comunicati stampa

Guarda tutti i comunicati
06/10/2026
Eventi
Finanza
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Amylyx Pharmaceuticals to Present Topline Data from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia at ObesityWeek® 2026 Annual Meeting
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
23/09/2026
Web e Social Network
Eventi
Salute
Scienza
Farmaceutica
Biotecnologia
Amylyx Pharmaceuticals to Present at the Stifel 2026 Virtual Cardiometabolic Forum
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
08/09/2026
Eventi
Oncologia
Salute
Sanità
Medicina - Varie
Farmaceutica
Biotecnologia
Amylyx Pharmaceuticals to Present at the 24th Annual Morgan Stanley Global Healthcare Conference
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
20/08/2026
Finanza
Biotecnologia
Farmaceutica
Salute
Amylyx Pharmaceuticals Announces Pricing of an Upsized $500 Million Underwritten Public Offering of Common Stock
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
18/08/2026
Finanza
Biotecnologia
Farmaceutica
Salute
Amylyx Pharmaceuticals Announces $350.0 Million Proposed Public Offering of Common Stock
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
18/08/2026
Web e Social Network
Telefonia e Varie
Finanza
Industria
Igiene alimentare
Farmaceutica
Salute
Medicina - Varie
Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
17/08/2026
Web e Social Network
Telefonia e Varie
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Amylyx Pharmaceuticals to Announce Topline Results from its Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia on August 18, 2026
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
06/08/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Igiene alimentare
Salute
Farmaceutica
Medicina - Varie
Amylyx Pharmaceuticals Reports Second Quarter 2026 Financial Results
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
03/08/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Amylyx Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 6, 2026
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
23/06/2026
Eventi
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0